Please login to the form below

Not currently logged in
Email:
Password:

sales models

This page shows the latest sales models news and features for those working in and with pharma, biotech and healthcare.

Choices, choices...

Choices, choices...

And just as different biological species make different choices, then different business models are characterised by the risk and return trade-offs they make. ... This is true not just between companies but also between different business models within

Latest news

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    representative-led sales models. ... Worse still, only 11% provide their sales force with an integrated customer database that bridges all channels - meaning omnichannel customer intelligence remains low.

  • Choose or lose Choose or lose

    In biology, peaks represent successful species and, in the life science industry, peaks represent successful business models. ... How is this relevant? Well, it implies that hybrid business models will fail and business models that represent clear

  • The Italian Job The Italian Job

    The Italian Job. Therapy efficacy and value-based reimbursement models. In my August column in this publication, I spoke about the need for establishing a mechanism that would allow stakeholders to

  • Dive in: gaining leadership in a therapeutic area Dive in: gaining leadership in a therapeutic area

    Therapeutic area leadership was once defined simply by who had the biggest and best drug for that condition; the level of 'leadership' could usually be measured by sales figures, but times ... sales and its top-selling cancer drugs (Rituxan/MabThera,

  • The lost art of selling The lost art of selling

    Let's start with the humble sales aid. In my opinion we used to be pretty good at these. ... Lesson one - Sales aids should be created by people who understand how to sell.

More from news
Approximately 4 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits. ... Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales

  • Choosing destiny Choosing destiny

    To allow for this, firms ranked alternative models in relative, not absolute, terms. ... Build. Low relative risk. Manage. Focus. Table 2: A portfolio comparison of business models.

  • Healthcare business and operating models redefined Healthcare business and operating models redefined

    They must realise the fundamental impact new business models will have on their organisations. ... These models represent potential strategies and direction that life science companies can take.

  • M&A is now vital to pharma - but it's vital to get it right M&A is now vital to pharma - but it's vital to get it right

    deals. Senior leaders will need to ensure agility in their operating models so that they can anticipate and respond to challenges ahead.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Syndicated or dedicated sales force?

    Pharmaceutical companies commonly use outsourced sales teams to support their existing promotional efforts. ... Ashfield were the first to introduce syndicated sales teams over 10 years ago.

  • Infographic: Sales outsourcing as a change partner

    As a result, the pharma industry is exploring new sales and marketing models, evolving its strategies to meet these modern, multifaceted challenges.Traditionally, contract sales organisations (CSOs) have provided a flexible, ... The participants included

  • Ashfield publishes white paper on sales outsourcing as a change partner

    In response, the pharma industry is exploring new sales and marketing models, evolving its core strategies to meet these modern, multifaceted challenges. ... The participants included 14 senior sales and buying professionals from pharmaceutical companies

  • Infographic: Sales outsourcing as a change partner

    As a result, the pharma industry is exploring new sales and marketing models, evolving its strategies to meet these modern, multifaceted challenges.Traditionally, contract sales organisations (CSOs) have provided a flexible, ... The participants included

  • Ashfield publishes white paper on sales outsourcing as a change partner

    In response, the pharma industry is exploring new sales and marketing models, evolving its core strategies to meet these modern, multifaceted challenges. ... The participants included 14 senior sales and buying professionals from pharmaceutical companies

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics